The Study of Molecular Risk Panels (70-gene Assay) in Chinese Breast Cancer Patients
NCT02669745 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 64
Last updated 2019-07-02
Summary
This study is experimental and will prospectively assess the proportion of patients in the two (2) MammaPrint Risk categories in patients of Chinese descent.
Conditions
- Chinese
Sponsors & Collaborators
-
Agendia
lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- FEMALE
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2012-01-31
- Primary Completion
- 2019-05-31
- Completion
- 2019-05-31
Countries
- United States
Study Locations
More Related Trials
-
Genetic and Protein Profiling in Normal and Cancerous Breast Tissue
NCT00083733 ·Status: COMPLETED
-
Exploratory Research on Constructing a Computational Biological Model Based on NGS for MRD After Breast Cancer Surgery
NCT06595966 ·Status: RECRUITING
-
Application of CfDNA Methylation Detection in Auxiliary Diagnosis of Breast Cancer
NCT06876610 ·Status: RECRUITING
-
Mutation of BRCA1/2 and Other Potential Genes in Triple-negative Breast Cancer
NCT02670668 ·Status: UNKNOWN ·Phase: NA
-
Identification of Biomarkers in Women at High Risk or Average Risk of Breast Cancer
NCT00897416 ·Status: COMPLETED
-
Clinical Value of Next Generation Sequencing in Endocrine Therapy for Advanced Hormone Receptor Positive/HER-2 Negative Breast Cancer
NCT03786575 ·Status: UNKNOWN ·Phase: NA
-
Prognosis and Targeted Therapy Related Molecular Screening Program for Patients of Breast Cancer in China
NCT03792529 ·Status: UNKNOWN
-
Clinical Application of Circulating Tumor DNA (ctDNA) in Patients With Late-stage Breast Cancer
NCT05079074 ·Status: COMPLETED
-
Breast Cancer Biomarker Sample Collection for the dtectDx Assay Verification
NCT01839045 ·Status: UNKNOWN
-
Breast Cancer Biomarker Sample Collection for the dtectDx v2 Assay Proof of Concept Protocol
NCT02078570 ·Status: UNKNOWN
-
Establishment of Normal Breast Epithelial Cell Lines From Patients at High Risk for Breast Cancer
NCT00001496 ·Status: COMPLETED
-
East Asian Breast Cancer Genome Atlas and Recurrence Risk Prediction
NCT04344496 ·Status: RECRUITING
-
MRD in High-risk EBC
NCT06566729 ·Status: ACTIVE_NOT_RECRUITING
-
Evaluation of Prognostic Monitoring for Women Who Have Completed Standard Treatment for Breast Cancer
NCT04145960 ·Status: UNKNOWN
-
Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy
NCT01198301 ·Status: COMPLETED
-
The Association Between Plasma Metabolites and the Risk, Efficacy and Prognosis in Early Breast Cancer
NCT06698679 ·Status: RECRUITING
-
RecurIndex Predicts Risk of Recurrence in Early-stage Luminal Breast Cancer
NCT04972448 ·Status: NOT_YET_RECRUITING
-
Clinical Application of ctDNA in Early Screening of Breast Cancer
NCT03973034 ·Status: UNKNOWN
-
Genomic Markers for Measuring Breast Cancer Response to Neoadjuvant Chemotherapy
NCT03709134 ·Status: COMPLETED
-
Treatment Intermittent Periods Based on ctDNA-MRD（Circulating Tumor DNA-minimal Residual Disease） Status in Advanced HER2-Positive Breast Cancer
NCT07132502 ·Status: NOT_YET_RECRUITING
-
99mTc-MIRC213 SPECT/CT for the Detection of HER2-positive Breast Cancer
NCT05622240 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
Study on Early Auxiliary Diagnosis and Postoperative Recurrence Monitoring of Breast Cancer
NCT05858242 ·Status: RECRUITING
-
Evaluation of Prognostic Monitoring for Triple Negative Breast Cancer Patients
NCT04145947 ·Status: UNKNOWN
-
Molecular Breast Imaging in Screening Breast Cancer
NCT03082456 ·Status: COMPLETED ·Phase: NA
-
A Nation-wide Multicenter Clinical Epidemiologic Study of Chinese Females With Advanced Breast
NCT03047889 ·Status: UNKNOWN